agilon health Inc (AGL)vsEli Lilly and Company (LLY)
AGL
agilon health Inc
$96.90
+9.00%
HEALTHCARE · Cap: $1.57B
LLY
Eli Lilly and Company
$1,180.16
-2.24%
HEALTHCARE · Cap: $1.02T
Smart Verdict
WallStSmart Research — data-driven comparison
Eli Lilly and Company generates 1141% more annual revenue ($72.25B vs $5.82B). LLY leads profitability with a 35.0% profit margin vs -6.1%. LLY earns a higher WallStSmart Score of 76/100 (B+).
AGL
Hold37
out of 100
Grade: F
LLY
Strong Buy76
out of 100
Grade: B+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 301.0% YoY
Conservative balance sheet, low leverage
Mega-cap, among the largest globally
Every $100 of equity generates 79 in profit
Keeps 35 of every $100 in revenue as profit
Strong operational efficiency at 49.4%
Revenue surging 55.5% year-over-year
Earnings expanding 169.9% YoY
Areas to Watch
Trading at 8.9x book value
Distress zone — elevated risk
Smaller company, higher risk/reward
Operating margin of 0.7%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Elevated debt levels
Trading at 33.8x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : AGL
The strongest argument for AGL centers on EPS Growth, Debt/Equity.
Bull Case : LLY
The strongest argument for LLY centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 35.0% and operating margin at 49.4%. Revenue growth of 55.5% demonstrates continued momentum.
Bear Case : AGL
The primary concerns for AGL are Price/Book, Altman Z-Score, Market Cap.
Bear Case : LLY
The primary concerns for LLY are PEG Ratio, P/E Ratio, Debt/Equity. Debt-to-equity of 1.62 is elevated, increasing financial risk.
Key Dynamics to Monitor
AGL profiles as a turnaround stock while LLY is a growth play — different risk/reward profiles.
AGL carries more volatility with a beta of 3.05 — expect wider price swings.
LLY is growing revenue faster at 55.5% — sustainability is the question.
LLY generates stronger free cash flow (7.8B), providing more financial flexibility.
Bottom Line
LLY scores higher overall (76/100 vs 37/100), backed by strong 35.0% margins and 55.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
agilon health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
agilon health, inc. The company is headquartered in Long Beach, California.
Visit Website →Eli Lilly and Company
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?